Version May 2024
Relief of dryness and itching: Topical: Apply twice daily.
Refer to adult dosing.
The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.
Frequency not defined: Dermatologic: Burning, mild stinging, peeling
Hypersensitivity to lactic acid or any component of the formulation
Concerns related to adverse effects:
• Photosensitivity: May cause photosensitivity; minimize exposure to the sun of areas being treated.
• Skin Irritation: Mild burning, stinging, or peeling may occur with use; discontinue if irritation occurs.
Other warnings/precautions:
• Appropriate use: For external use only; not for use near eyes, lips, or mucous membranes.
Excipient information presented when available (limited, particularly for generics); consult specific product labeling.
Cream, External:
Generic: 10% (113.4 g, 226.8 g)
Lotion, External:
Generic: 10% (354.84 mL, 473.12 mL)
Yes
Lotion (Lacticare External)
5% (222 mL): $8.52
Disclaimer: The pricing data provide a representative AWP and/or AAWP price from a single manufacturer of the brand and/or generic product, respectively. The pricing data should be used for benchmarking purposes only, and as such should not be used to set or adjudicate any prices for reimbursement or purchasing functions. Pricing data is updated monthly.
Relief of dryness and itching: Lubricate and moisturize the skin to relieve dryness and itching.
None known.
Note: Interacting drugs may not be individually listed below if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed). For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.
Calcipotriene: Lactic Acid may diminish the therapeutic effect of Calcipotriene. Management: Monitor for reduced calcipotriene efficacy if combined with lactic acid. Consider separating the administration of these agents by 10 to 12 hours to minimize the risk of this potential interaction. Risk C: Monitor therapy
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
